Skip to main content
TipRanks
Go Ultimate75% OFF

Walter Phd Lovenberg Insider Profile

4 Followers

Walter Phd Lovenberg, former Director at Merrimack Pharmaceuticals, holds 84.03K shares in Merrimack Pharmaceuticals (Ticker: MACK). Most recently, Walter Phd Lovenberg Bought 5,462 shares of Merrimack Pharmaceuticals on Apr 27, 2012 for an estimated value of $11.96K.

Walter Phd Lovenberg's Trading History

MACK
Merrimack Pharmaceuticals
Apr 27, 2012―Informative Buy11.96K$1.27M
MACK
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 27, 2012Informative Buy$11.96K5,462$2.19-27.10%
Apr 05, 2012Informative Buy$10.00K1,428$7.00+1.40%
Apr 05, 2012Uninformative Buy$0.007,143$0.00―
Feb 01, 2012Uninformative Buy―70,000$0.06―

You May Also Like

Walter Phd Lovenberg insider profile FAQ

What is the percentage of profitable transactions made by Walter Phd Lovenberg?
The percentage of profitable transactions made by Walter Phd Lovenberg is 50%.
What is the average return per transaction made by Walter Phd Lovenberg?
The average return per transaction made by Walter Phd Lovenberg is -12.80%.
What stocks does Walter Phd Lovenberg hold?
Walter Phd Lovenberg holds: MACK stocks.
What was Walter Phd Lovenberg’s latest transaction?
Walter Phd Lovenberg’s latest transaction was an Informative Buy of $11.96K.
What was Walter Phd Lovenberg's most profitable transaction?
Walter Phd Lovenberg’s most profitable transaction was an Informative Buy of MACK stock on April 5, 2012. The return on the trade was 1.40%.
What is Walter Phd Lovenberg's role in Merrimack Pharmaceuticals?
Walter Phd Lovenberg's role in Merrimack Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.